The Voss Lab Report:

Check out the latest announcements, scientific discoveries, and more from the Voss Lab!

06/03/25

Dr. Voss has been voted to join the CIC membership!

Dr. Voss has joined the Beirne B. Carter Center for Immunology Research (CIC) membership. Check out the highlight article here: https://www.immunology.virginia.edu/member-update-kelsey-voss-phd/

05/21/25

Now accepting Post Doctoral Research Associates!

We are now accepting Postdoctoral Research Associates to work in the Voss Lab at the University of Virginia! The focus of this lab position is to lead a research project centered on type 1 diabetes (T1D) with a focus on ferroptosis and iron metabolism. For more information, and to apply to this position, please refer to the following link: https://uva.wd1.myworkdayjobs.com/UVAJobs/job/Charlottesville-VA/Postdoctoral-Research-Associate-in-Pharmacology--Voss-Lab-_R0072659

04/29/25

Now accepting PhD Rotation Students in Fall 2025!

Are you a curious, motivated PhD student looking for an exciting and supportive lab for your upcoming rotation? Our lab is inviting rotation students to join us this Fall 2025. Whether you're interested in iron metabolism, or just want to see if our research is the right fit for you, we’d love to connect!

03/26/25

Dr. Voss Article Feature: "From Breakthrough T1D trainee to Principal Investigator: Kelsey Voss, Ph.D., is calling the shots"

Dr. Voss was featured in an article by Breakthrough T1D titled "From Breakthrough T1D trainee to Principal Investigator: Kelsey Voss, Ph.D., is calling the shots," highlighting her accomplishments and exemplary leadership in honor of Women's History Month!

Read Here:

03/25/25

Exciting News: We are pleased to announce our Research Study is IRB approved and live!!

We are pleased to announce that our research study, exploring Iron Metabolism in Autoimmune Diseases, has been officially approved by the Institutional Review Board (IRB) and is now live! This is a significant step forward in our research, and with this approval, we have begun to enroll participants in our study.